Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Gazyva (obinutuzumab)
pCPA File Number:
21082
Negotiation Status:
Negotiations were not pursued
Indication(s):
Follicular Lymphoma
Sponsor/Manufacturer:
Hoffmann-La Roche
CADTH Project Number:
pCODR 10126
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
2018-12-07